Latin America Generic Drug Market Share, Size, Growth, Opportunity and Forecast 2021-2026

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Latin America Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The Latin America generic drug market is currently witnessing strong growth. Generic drugs are bioequivalent of innovator drugs in terms of dosage, risks, strength, side effects and intended usage. These drugs can differ from their branded counterparts in size, color, shape and packaging. They are sold at lower prices as they do not require investments in clinical studies to demonstrate the effectiveness of the medicine. Consequently, the demand for generic drugs is rising in the Latin American region.

The significant pediatric population, along with the increasing number of individuals who have Alzheimer’s disease, osteoarthritis, and rheumatoid arthritis, represents one of the key factors propelling the growth of the generic drug market in the Latin American region. Moreover, governing authorities in the region are investing in the healthcare sector, which is contributing to the market growth. Other factors, such as the burgeoning pharmaceutical industry and inflating income levels of individuals, are driving the market further. However, the recent outbreak of the coronavirus disease (COVID-19) pandemic and the imposition of lockdown restrictions have halted the production of generic drugs, which has negatively impacted the market. The market will recover once lockdown relaxations are introduced. Looking forward, the market is expected to continue its moderate growth during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Latin America generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.

Breakup by Segment:

Unbranded Generics
Branded Generics

Breakup by Therapy Area:

Central Nervous System
Cardiovascular
Dermatology
Genitourinary/Hormonal
Respiratory
Rheumatology
Diabetes
Oncology
Others

Breakup by Drug Delivery:

Oral
Injectables
Dermal/Topical
Inhalers

Breakup by Distribution Channel:

Retail Pharmacies
Hospital Pharmacies

Breakup by Country:

Brazil
Mexico
Argentina
Columbia
Chile
Peru
Others

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

How has the Latin America generic drug market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Latin America generic drug market?
What are the key regional markets?
What is the breakup of the market based on the segment?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the drug delivery?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the Latin America generic drug market and who are the key players?
What is the degree of competition in the industry?